TScan Therapeutics, Inc.
TCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001783328
No open-market purchases or sales by TScan Therapeutics, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $35.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in TScan Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +5 vs. Q2 2023
- Shares held
- 28.6M
- +836.6K (+3.0%) vs. Q2 2023
- Total value
- $73.2M
- +$3.82M (+5.5%) vs. Q2 2023
- New holders
- 6
- 10 more added
- Sold out
- 1
- 1 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $35.1M |
| Q1 2026 | 60 | $32.8M |
| Q4 2025 | 61 | $30.7M |
| Q3 2025 | 73 | $62.9M |
| Q2 2025 | 81 | $51.8M |
| Q1 2025 | 92 | $55.4M |
| Q4 2024 | 89 | $126.2M |
| Q3 2024 | 89 | $208.3M |
| Q2 2024 | 81 | $242.6M |
| Q1 2024 | 66 | $272.3M |
| Q4 2023 | 54 | $186.1M |
| Q3 2023 | 32 | $73.2M |
| Q2 2023 | 28 | $69.9M |
| Q1 2023 | 28 | $20.3M |
| Q4 2022 | 28 | $14.8M |
| Q3 2022 | 26 | $29.0M |
| Q2 2022 | 24 | $30.4M |
| Q1 2022 | 25 | $26.3M |
| Q4 2021 | 29 | $44.4M |
| Q3 2021 | 27 | $83.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding TScan Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 5,224,600 | $13.4M | 8.85% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 5,000,000 | $12.8M | 0.44% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 4,000,000 | $10.2M | 0.02% | 00.0% | Unchanged |
| BVF Inc | 2,989,474 | $7.65M | 0.21% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,784,792 | $7.13M | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,752,594 | $4.49M | 0.00% | +393,305+28.9% | Added |
| BlackRock Inc. | 1,680,449 | $4.30M | 0.00% | +416,996+33.0% | Added |
| Deer Management Co. LLC | 1,245,505 | $3.19M | 0.39% | 00.0% | Unchanged |
| Alphabet Inc. | 1,077,080 | $2.76M | 0.18% | 00.0% | Unchanged |
| Simplify Asset Management Inc. | 1,046,916 | $2.68M | 0.44% | 00.0% | Unchanged |
| DC Funds, LP | 630,000 | $1.61M | 33.20% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 307,938 | $788.6K | 0.00% | +191,047+163.4% | Added |
| Morgan Stanley | 259,447 | $664.2K | 0.00% | +150,972+139.2% | Added |
| Stifel Financial Corp | 116,900 | $299.3K | 0.00% | +17,900+18.1% | Added |
| NewEdge Wealth, LLC | 91,463 | $234.1K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 88,300 | $226.0K | 0.01% | +38,300+76.6% | Added |
| Northern Trust Corp | 71,976 | $184.3K | 0.00% | +56,921+378.1% | Added |
| State Street Corp | 41,700 | $106.8K | 0.00% | +3,200+8.3% | Added |
| DC Investments Management, LLC | 35,563 | $91.0K | 0.11% | 00.0% | Unchanged |
| Letko, Brosseau & Associates Inc | 32,400 | $82.9K | 0.00% | +32,400 | New |
| American Century Companies Inc | 19,212 | $49.2K | 0.00% | +19,212 | New |
| Renaissance Technologies LLC | 17,700 | $45.0K | 0.00% | −129,762−88.0% | Reduced |
| Susquehanna International Group, LLP | 16,915 | $43.3K | 0.00% | +16,915 | New |
| Pale Fire Capital SE | 16,575 | $42.4K | 0.00% | +16,575 | New |
| Privium Fund Management (UK) Ltd | 15,825 | $41.5K | 0.03% | 00.0% | Unchanged |
| Aries Wealth Management | 10,000 | $35.3K | 0.01% | +10,000 | New |
| Waldron Private Wealth LLC | 10,000 | $25.6K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 2,410 | $6.17K | 0.00% | +2,410 | New |
| UBS Group AG | 1,115 | $2.85K | 0.00% | +15+1.4% | Added |
| Atlas Capital Advisors LLC | 896 | $2.29K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 286 | $732 | 0.00% | +206+257.5% | Added |
| Bank of America Corp | 200 | $512 | 0.00% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |